RSRahul K. Sharma

Rahul K. Sharma

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rahul K. Sharma has a total of 153 co-authors. Here are the top co-authors by number of shared publications:

  • Scott J. Stephan

    Carol and John S. Odess Chair in Facial Plastic and Reconstructive Surgery, Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology – Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA

    14 shared publications
  • Priyesh N. Patel

    Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology – Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA

    10 shared publications
  • Shiayin F. Yang

    Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology – Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA

    7 shared publications
  • Shiayin F. Yang

    Department of Otolaryngology‐Head & Neck Surgery Vanderbilt University Medical Center Nashville Tennessee USA

    7 shared publications
  • Justin S. Golub

    Department of Otolaryngology‐Head and Neck Surgery Columbia University Vagelos College of Physicians and Surgeons, NewYork‐Presbyterian/Columbia University Irving Medical Center New York New York USA

    5 shared publications
  • Priyesh N. Patel

    Department of Otolaryngology-Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    5 shared publications

Latest Publications

  • Open Access

    Periocular Facial Nerve Axonal Analysis and Anatomical Localization: Implications for Blink Reanimation

    by Nomongo Dorjsuren, Jarrett M. Jackson, Rahul Sharma, Connie Ma, Monica Rossi Meyer, Priyesh Patel, Shi Yang, Scott Stephan, Jordan Garcia

    Background: Cross-face nerve grafting is widely performed in smile reanimation, but its application in dynamic blink restoration is less well characterized. Objectives: To compare axon counts of the frontal, zygomatic, and periorbital branches of the facial nerve in human anatomical specimens to provide insight on their suitability in cross-face nerve grafting surgery. Methods: Four human anatomical specimens (eight hemifaces) were dissected. Facial nerve specimens were processed for histological cross-sectional analysis using FluoroMyelin staining. Quantitative axon analysis was conducted using semiautomated dot annotation in opensource QuPath software. Axon counts were compared using one-way analysis of variance (ANOVA). Results: The study included four male human anatomical specimens with an average age of 71 years. Mean axon counts were 405.0 for the frontal branch, 367.4 for the zygomatic branch, and 285.8 for the orbicularis branch. Substantial variability was observed across specimens. ANOVA did not detect a difference in mean axon count ( p = 0.0757). Lateral orbicularis oculi branches were identified in all hemifaces and commonly arose directly from the upper facial nerve trunk. Conclusion: This study demonstrates that sampled frontal, zygomatic, and orbicularis oculi facial nerve branches had axon counts that were not detectably different in this human anatomical specimen cohort.

  • Open Access

    Compensation Structures, Job Satisfaction, and Retention of Facial Plastic Surgeons in Academic Practices

    by Julia R. Brennan, Andrew Chen, Jaymie A. Bromfield, Rahul Sharma, Steven Mobley, Douglas M. Sidle, James C. Wang

    Objective: To understand how various compensation models are structured nationwide and to evaluate how these models impact the stability of the academic facial plastic surgeon workforce. We hypothesize that competitive compensation structure plays a critical role in retention of academic departments and aim to gain insights into financial factors at play in sustaining this workforce. Methods: This cross‐sectional survey study examined responses from a 25‐item electronic questionnaire sent to American Academy of Facial Plastic and Reconstructive Surgery members from July 2023 to January 2024. Results: Of 59 respondents, 45 (76%) reported employment by academic medical centers, representing 19% of academic facial plastic surgeons in the US. Compensation included production‐based relative value units (RVU) ( n = 17, 38%), collections‐based (10, 22%), salary (9, 20%), or a combination of models (9, 20%). In strict RVU models, compensation ranged from $41–91 per RVU (median $60, IQR: $58–66); 84% reported no cap on RVUs, and the median target before incentives was 7500 (IQR: 6690–9000). 56% were satisfied with their income, and 62% were unlikely to leave academia within 5 years, with satisfaction associated with lower intent to leave ( p = 0.038). Conclusion: Findings show that competitive compensation structures in academic facial plastic surgery are associated with greater job satisfaction as well as lower intent to leave academics. This study provides greater transparency surrounding compensation structure for academic facial plastic surgeons while providing insight into financial factors playing a role in their retention within academia. Level of Evidence: Level 5.

  • Risk Factors of Persistent Opioid Use After Forehead Flap Reconstruction

    by Alexander J. Barna, Rahul K. Sharma, Nicole G. DeSisto, Scott J. Stephan, Priyesh N. Patel, Shiayin F. Yang

    Purpose: To assess the risk of persistent opioid use after forehead flaps with preserved vascular pedicles. Materials and methods: This multi-center cohort study used the TriNetX, LLC US Collaborative Network to identify patients undergoing forehead flaps with preservation of the vascular pedicle. Patients were grouped based on whether they received an opioid prescription within 1 week of surgery. Propensity matching controlled for age, race, sex, pain diagnoses, and previous opioid use. Baseline characteristics were analyzed with t -tests and chi-squares. Risk ratios assessed associations between variables and development of new persistent opioid use (new opioid prescription 3-9 months after forehead flap reconstruction). Results: Overall, 7214 patients (3280 female [45.5%]) underwent forehead flap reconstruction with preservation of the vascular pedicle and 2660 (36.9%) receive a postoperative opioid prescription. Unadjusted analysis demonstrated a statistically significant association between gender and receipt of a postoperative opioid prescription, with male patients more likely than female patients to receive an opioid prescription (χ 2 = 14.94, P < .001). After propensity score matching, 1352 patients (588 women [43.3%]) with a mean (SD) age of 67.3 (14.7) years, were included for analysis. Patients who receive a postoperative opioid prescription were at 3.21 times greater risk of developing new persistent opioid use compared to patients not prescribed postoperative opioids (RR = 3.21; 95% CI (2.27, 4.52)). Conclusions: Patients who receive postoperative opioid prescriptions after forehead flap reconstruction may be at greater risk of developing new persistent opioid use.

  • Nationwide Analysis of Head and Neck Imaging for Bell's Palsy: Insights From Healthcare Claims

    by Sujay Ratna, Rahul Sharma, Eric Gong, Joshua Rosenberg, Mingyang Gray

    Introduction: Professional society guidelines recommend against routine diagnostic imaging for suspected Bell's palsy at initial presentation. This study examines national trends in imaging use, adherence to guidelines, and the utility of CT and MRI in treatment practices. Methods: A retrospective cohort study of 35,942 adult Bell's palsy patients using ICD‐9‐CM and ICD‐10‐CM diagnosis codes from 2016 to 2021 was conducted. These patients were continuously enrolled for ≥ 1 year in the employer‐sponsored MarketScan commercial or Medicare outpatient and prescription drugs claims data. The main outcomes of interest were CT and MRI scan usage at or after the diagnosis date. Results: CT scans were performed in 27% of patients (median time: 3 days), while MRI was performed in 25% (median time: 36 days). Within 30 days of their index claim, 16% underwent CT scanning and 12% underwent MRI. Patients on combination therapy (steroids and antivirals) had significantly higher rates of early imaging (CT: 38% vs. 25%, p < 0.001; MRI: 19% vs. 17%, p < 0.001) compared to monotherapy. CT imaging within 30 days of index diagnosis was strongly associated with combination therapy (OR = 3.49, 95% CI = 3.28–3.73, p < 0.001), as was early MRI to a lesser extent (OR = 1.26, 95% CI = 1.17–1.35, p < 0.001). Imaging was most frequent in acute care settings, and median costs rose significantly with dual‐modality imaging ( p < 0.001). Conclusion: CT and MRI are frequently used in Bell's palsy despite guideline recommendations, especially in patients receiving combination therapy. This study finds an association between diagnostic imaging for Bell's palsy and combination therapy, highlighting opportunities to reduce unnecessary testing and promote guideline‐based care. Level of Evidence: 3.


  • Open Access

    The Impact of Social Determinants of Health on Facial Synkinesis Severity

    by Alexander J. Barna, Amy Wang, Nicole G. DeSisto, Rahul K. Sharma, Scott J. Stephan, Priyesh N. Patel, Shiayin F. Yang


  • Top Cited Papers

    Radiographic Midfacial Volume Changes in Patients on GLP‐1 Agonists

    by Rahul K. Sharma, Kelly L. Vittetoe, Alexander J. Barna, Sahar Takkouche, Antonios N. Varelas, Shiayin F. Yang, Scott J. Stephan, Priyesh N. Patel

    Objective: Facial plastic surgeons report seeing an increase in patients presenting with facial deflation and a prematurely aged appearance—a reported side effect of the weight‐loss drug semaglutide. No objective data exist to quantitatively characterize midface volume loss in these patients.Study Design: Retrospective cohort study.Setting: Single, tertiary academic medical center.Methods: Hospital‐level electronic medical record data were systematically queried for patients with glucagon‐like peptide‐1 (GLP‐1) agonist prescriptions as well as head and neck imaging (computed tomography [CT]/magnetic resonance [MR]) both before and after prescriptions between 2017 and 2024. Changes in total, superficial, and deep midface volume were measured. Spearman correlation and linear regression were conducted to understand the relationship between weight‐loss magnitude and facial volume changes.Results: Twenty patients with available imaging were included in the analysis. The median age of patients was 54 years (interquartile range [IQR] 48‐61). The average duration of GLP‐1 agonists was 321 days (SD = 291), and the average weight loss was 11.0 kg (SD = 6.9). The median percent decrease in total midfacial volume was 9.0% (IQR 3%‐14%). Superficial volume decreased by 11.0% (IQR 5%‐15%), and deep volume decreased by 7.0% (IQR −20% to 15%). Spearman correlation showed a relationship between weight loss and superficial volume loss (rho = 0.590, P = .006) but not deep volume loss (r = 0.115, P = .629). Linear regression showed a loss of 7% facial volume for every 10 kg of weight lost (r = 0.063, SE = 0.003, P = .0293).Conclusion: Patients on average can expect a loss of 7% of midfacial volume/10 kg of total weight loss, primarily in superficial fat pads. This represents one of the first quantitative assessment of the “Ozempic face” phenomenon.


  • Open Access

    Initial Treatment and Referral Patterns for Acute Facial Palsy: Insights From Emergency Department Practices

    by Christine C. Little, Rahul K. Sharma, Alexander Barna, Priyesh N. Patel, Scott J. Stephan, Shiayin F. Yang

    Objectives: To investigate variations in Bell's Palsy treatment and referrals within the Emergency Department (ED), with a focus on sociodemographic and provider‐related factors. Methods: A retrospective cohort review was performed including patients with a new diagnosis of Bell's Palsy or acute facial paralysis treated at a single, tertiary academic ED between 2017 and 2024. Management practices, including the use of steroids, antivirals, imaging, specialty consultations, and referrals, were evaluated across sociodemographic variables and provider types. Multivariable logistic regression was used to identify differences in management practices. Results: The final cohort comprised 887 patients. Of these, 82.1% received steroids, 57.7% received antivirals, and 57.3% underwent imaging. Hispanic patients were significantly less likely to receive imaging (OR 0.48, p = 0.006), whereas older patients were more likely to undergo imaging (OR 1.04, p < 0.001). Patients with Medicare and Medicaid insurance were less likely to receive bimodal therapy (steroids with antivirals) compared to private insurance holders (OR 0.30, p < 0.001 and OR 0.49, p < 0.001, respectively). Residents and fellows were more likely to obtain specialty consults (OR 2.51, p < 0.001) and imaging (OR 1.42, p = 0.043) than attending physicians. Nearly one third of patients received subspecialty consultation by neurology (26.0%), otolaryngology (6.2%), or plastic surgery (0.2%). Conclusions: Despite increasing awareness regarding the treatment of acute facial palsy, this study reveals existing disparities in initial management by age, insurance status, race, and provider type. Efforts should focus on increasing provider awareness of treatment guidelines to standardize management protocols for improved care delivery and equity. Level of Evidence: 4.


  • Applications of Artificial Intelligence in Facial Plastic and Reconstructive Surgery: A Narrative Review

    by Feyisayo O. Adegboye, April A. Peterson, Rahul K. Sharma, Scott J. Stephan, Priyesh N. Patel, Shiayin F. Yang

    Importance: Artificial intelligence (AI) has made invaluable contributions to the technologic advancements across many fields. It is transforming health care and may have a role in improving patient outcomes in facial plastic and reconstructive surgery (FPRS). Observations: In recent years, new automated approaches to simulating and analyzing outcomes using AI have emerged. Advances in rhinoplasty, facelifts, orthognathic surgery, facial reanimation, and preoperative consultation are currently being developed in FPRS. Conclusions and Relevance: Applications of AI have been applied to assist facial plastic surgeons in the preoperative stage, intraoperative planning process, and objective assessment of postoperative outcomes. The application of AI provides avenues to improve postoperative outcomes, while also optimizing patient care.


  • Electromyography-Guided Chemodenervation for Treatment of Nonflaccid Facial Palsy: Analysis of Accuracy

    by Feyisayo O. Adegboye, Montana K. Upton, Rahul K. Sharma, Emily R. Rebula, Alexander J. Barna, Priyesh N. Patel, Scott J. Stephan, Shiayin F. Yang

    Background: Chemodenervation is a mainstay in the treatment of nonflaccid facial paralysis (NFFP). This study investigates how electromyography (EMG) guidance during chemodenervation may allow for more accurate needle placement. Study Objective: To compare the accuracy with needle EMG chemodenervation compared with standard non-EMG approaches in patients receiving treatment for NFFP with botulinum toxin (BT) as measured by physician and EMG verification. Methods: The use of needle EMG across three surgeons was recorded to determine if the use of EMG changed the location, angle, or depth of needle insertion into the targeted facial muscle. The determination of accurate needle placement was self-reported by the physician coupled with the physician assessment of muscle EMG activity. Accuracy was determined as the ratio of the number of successful EMG needle insertions (placed within muscle with adequate signal) over the total number of EMG needle insertions. Results: A total of 137 patients underwent treatment for NFFP, with an average age of 54 (interquartile range [IQR]: 44–65) and weight of 73 kg (IQR: 64–90). Of the 14 facial mimetic muscles, the posterior belly of digastric (accuracy = 19%, standard deviation [SD] 0.4), risorius (accuracy = 46%, SD 0.5), and zygomaticus (accuracy = 47%, SD 0.5) had the lowest accuracy in BT placement (Table 3). Of all the muscles included, only the buccinator ( p = 0.015), platysma ( p = 0.0093), and zygomaticus ( p = 0.024) had statistically significant variation in the accuracy of BT placement between surgeons. Conclusions: EMG guidance for the treatment of NFFP may improve the precision of needle placement and BT delivery, particularly in the mid and lower facial muscles.